AstraZeneca PLC (AZN) vs Medtronic plc (MDT)
AZN leads on 14 of 17 compared metrics.
A side-by-side comparison of AstraZeneca PLC and Medtronic plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
AZN
AstraZeneca PLC
$164.52HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT
MDT
Medtronic plc
$83.29HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT
Total return — AZN vs MDT
growth of $100 · dividends reinvested · last 30yAZN +1949.5%MDT +1016.3%AZN compounded faster
AZN MDT
AZN vs MDT: by the numbers
- •AZN is the larger company ($127.48B vs $106.62B market cap).
- •AZN trades at the lower earnings multiple (12.39 vs 22.31 P/E).
- •AZN converts more revenue to profit (17.19% vs 13.20% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 5.18% CAGR).
- •MDT pays the higher dividend yield (3.43% vs 1.95%).
Which is better, AZN or MDT?
Metric tally: AZN 14 · MDT 3It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeMDT(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | MDT |
|---|---|---|
| P/E ratio | 12.39● | 22.31 |
| Forward P/E | 16.07 | 15.08● |
| P/S ratio | 2.12● | 2.95 |
| P/B ratio | 2.71 | 2.17● |
| PEG ratio | 0.29● | 6.72 |
| EV / EBITDA | 7.69● | 14.27 |
| FCF yield | 6.29%● | 5.06% |
Profitability
| Metric | AZN | MDT |
|---|---|---|
| Gross margin | 81.68%● | 65.02% |
| Operating margin | 23.69%● | 17.78% |
| Net margin | 17.19%● | 13.20% |
| ROE | 21.95%● | 9.70% |
| ROIC | 13.03%● | 6.13% |
Dividends
| Metric | AZN | MDT |
|---|---|---|
| Dividend yield | 1.95% | 3.43%● |
| Payout ratio | 24.24% | 76.00% |
Growth (annualized)
| Metric | AZN | MDT |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 5.18% |
| EPS CAGR (5Y) | 22.02%● | 0.83% |
| FCF CAGR (5Y) | 15.68%● | 3.07% |
| Total return CAGR (5Y) | 9.53%● | -4.88% |
Frequently asked
- Which is better, AZN or MDT?
- It depends on your goal. value: AZN (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: MDT (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 14 to 3.
- Is AZN or MDT cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 12.39 P/E and MDT at 22.31.
- Which has grown faster, AZN or MDT?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus MDT at 5.18%.
- Does AZN or MDT pay a bigger dividend?
- AZN yields 1.95% and MDT yields 3.43% based on trailing dividends and the latest price.
- Is AZN or MDT more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus MDT at 13.20%.
- Which has been the better investment, AZN or MDT?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 13.66% versus MDT at 2.08%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioMedtronic P/E ratioAstraZeneca dividend yieldMedtronic dividend yieldAstraZeneca ROEMedtronic ROEAstraZeneca operating marginMedtronic operating marginAstraZeneca revenue growthMedtronic revenue growthAstraZeneca free cash flowMedtronic free cash flow
AstraZeneca & Medtronic appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 20, 2026.